GSK Launches Shingrix in India- A Vaccine for the Prevention of Shingles in Adults Aged 50 Years and above
Global data show that 1 out of 3 people develops shingles in a lifetime[i]The vaccine has proven efficacy of >90% against shingles[ii]Shingrix can provide at...
